203 related articles for article (PubMed ID: 35093747)
1. In Vitro characterization of the endocrine disrupting effects of per- and poly-fluoroalkyl substances (PFASs) on the human androgen receptor.
Tachachartvanich P; Singam ERA; Durkin KA; Furlow JD; Smith MT; La Merrill MA
J Hazard Mater; 2022 May; 429():128243. PubMed ID: 35093747
[TBL] [Abstract][Full Text] [Related]
2. Structure-based discovery of the endocrine disrupting effects of hydraulic fracturing chemicals as novel androgen receptor antagonists.
Tachachartvanich P; Azhagiya Singam ER; Durkin KA; Smith MT; La Merrill MA
Chemosphere; 2020 Oct; 257():127178. PubMed ID: 32505947
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the endocrine-disrupting ability of 49 per- and polyfluoroalkyl substances: In silico and epidemiological evidence.
Yu S; Ren J; Lv Z; Li R; Zhong Y; Yao W; Yuan J
Chemosphere; 2022 Mar; 290():133366. PubMed ID: 34933031
[TBL] [Abstract][Full Text] [Related]
4. Structure-based virtual screening of perfluoroalkyl and polyfluoroalkyl substances (PFASs) as endocrine disruptors of androgen receptor activity using molecular docking and machine learning.
Azhagiya Singam ER; Tachachartvanich P; Fourches D; Soshilov A; Hsieh JCY; La Merrill MA; Smith MT; Durkin KA
Environ Res; 2020 Nov; 190():109920. PubMed ID: 32795691
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the Interactions of a Large Number of Per- and Poly-Fluoroalkyl Substances with Ten Nuclear Receptors.
Azhagiya Singam ER; Durkin KA; La Merrill MA; Furlow JD; Wang JC; Smith MT
Environ Sci Technol; 2024 Mar; 58(10):4487-4499. PubMed ID: 38422483
[TBL] [Abstract][Full Text] [Related]
6. Identification of a group of brominated flame retardants as novel androgen receptor antagonists and potential neuronal and endocrine disrupters.
Kharlyngdoh JB; Pradhan A; Asnake S; Walstad A; Ivarsson P; Olsson PE
Environ Int; 2015 Jan; 74():60-70. PubMed ID: 25454221
[TBL] [Abstract][Full Text] [Related]
7. Endocrine Disruption at the Androgen Receptor: Employing Molecular Dynamics and Docking for Improved Virtual Screening and Toxicity Prediction.
Wahl J; Smieško M
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914135
[TBL] [Abstract][Full Text] [Related]
8. The triazole fungicide metconazole inhibits the homodimerization of human androgen receptors to suppress androgen-induced transcriptional activation.
Jung DW; Jeong DH; Kim UJ; Lee HS
Chem Biol Interact; 2023 Jun; 378():110489. PubMed ID: 37059213
[TBL] [Abstract][Full Text] [Related]
9. The environmental endocrine disruptor p-nitrophenol interacts with FKBP51, a positive regulator of androgen receptor and inhibits androgen receptor signaling in human cells.
Wu D; Tao X; Chen ZP; Han JT; Jia WJ; Zhu N; Li X; Wang Z; He YX
J Hazard Mater; 2016 Apr; 307():193-201. PubMed ID: 26780698
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of MEL-3, a novel AR antagonist that suppresses prostate cancer cell growth.
Helsen C; Marchand A; Chaltin P; Munck S; Voet A; Verstuyf A; Claessens F
Mol Cancer Ther; 2012 Jun; 11(6):1257-68. PubMed ID: 22496481
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of tetrabromobisphenol A effects on human glucocorticoid and androgen receptors: A comparison of results from human- with yeast-based in vitro assays.
Beck KR; Sommer TJ; Schuster D; Odermatt A
Toxicology; 2016 Aug; 370():70-77. PubMed ID: 27693315
[TBL] [Abstract][Full Text] [Related]
12. Human blood-based exposure levels of persistent organic pollutant (POP) mixtures antagonise androgen receptor transactivation and translocation.
McComb J; Mills IG; Muller M; Berntsen HF; Zimmer KE; Ropstad E; Verhaegen S; Connolly L
Environ Int; 2019 Nov; 132():105083. PubMed ID: 31470217
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of Bisphenol A on androgen receptor antagonism.
Huang X; Cang X; Liu J
Toxicol In Vitro; 2019 Dec; 61():104621. PubMed ID: 31415812
[TBL] [Abstract][Full Text] [Related]
14. Machine Learning Consensus To Predict the Binding to the Androgen Receptor within the CoMPARA Project.
Grisoni F; Consonni V; Ballabio D
J Chem Inf Model; 2019 May; 59(5):1839-1848. PubMed ID: 30668916
[TBL] [Abstract][Full Text] [Related]
15. Endocrine-disrupting activity of per- and polyfluoroalkyl substances: Exploring combined approaches of ligand and structure based modeling.
Kar S; Sepúlveda MS; Roy K; Leszczynski J
Chemosphere; 2017 Oct; 184():514-523. PubMed ID: 28622647
[TBL] [Abstract][Full Text] [Related]
16. In silico binding of 4,4'-bisphenols predicts in vitro estrogenic and antiandrogenic activity.
Conroy-Ben O; Garcia I; Teske SS
Environ Toxicol; 2018 May; 33(5):569-578. PubMed ID: 29392883
[TBL] [Abstract][Full Text] [Related]
17. In silico and in vitro assessment of androgen receptor antagonists.
Serçinoğlu O; Bereketoglu C; Olsson PE; Pradhan A
Comput Biol Chem; 2021 Jun; 92():107490. PubMed ID: 33932781
[TBL] [Abstract][Full Text] [Related]
18. Priority list of potential endocrine-disrupting chemicals in food chemical contaminants: a docking study and in vitro/epidemiological evidence integration.
Ren J; Jin T; Li R; Zhong YY; Xuan YX; Wang YL; Yao W; Yu SL; Yuan JT
SAR QSAR Environ Res; 2023; 34(10):847-866. PubMed ID: 37920972
[TBL] [Abstract][Full Text] [Related]
19. Molecular interactions of vinclozolin metabolites with human estrogen receptors 1GWR-α and 1QKM and androgen receptor 2AM9-β: Implication for endocrine disruption.
Habib H; Haider MR; Sharma S; Ahmad S; Dabeer S; Yar MS; Raisuddin S
Toxicol Mech Methods; 2020 Jun; 30(5):370-377. PubMed ID: 32208804
[No Abstract] [Full Text] [Related]
20. Endocrine Disruptor Potential of Short- and Long-Chain Perfluoroalkyl Substances (PFASs)-A Synthesis of Current Knowledge with Proposal of Molecular Mechanism.
Mokra K
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
